| activity-related pain intensity (participant assessment) | Activity-related pain improved by 19.5 vs placebo in 139 people over 12 weeks. (p = 0.046)Benefit seen | 19.5 Recorded unit: Not reported | Sample (as reported): 139 Follow-up: 12 weeks | Randomised trial · 2017 Study detailsImprovement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Randomized Controlled Trial PMID 28177710 |
|---|
| activity-related pain intensity (physician assessment) | Activity-related pain improved by 16.7 vs placebo in 139 people over 12 weeks. (p = 0.021)Benefit seen | 16.7 Recorded unit: Not reported | Sample (as reported): 139 Follow-up: 12 weeks | Randomised trial · 2017 Study detailsImprovement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Randomized Controlled Trial PMID 28177710 |
|---|
| pain intensity under resting conditions | No significant benefit for resting pain vs placebo in 139 people over 12 weeks. (p = 0.209)No clear benefit | Not reported Recorded unit: Not reported | Sample (as reported): 139 Follow-up: 12 weeks | Randomised trial · 2017 Study detailsImprovement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Randomized Controlled Trial PMID 28177710 |
|---|
| range of motion of the knee joint | No significant change in knee range of motion vs placebo in 139 people over 12 weeks.No clear benefit | Not reported Recorded unit: Not reported | Sample (as reported): 139 Follow-up: 12 weeks | Randomised trial · 2017 Study detailsImprovement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Randomized Controlled Trial PMID 28177710 |
|---|
| use of additional therapeutic options | Use of additional treatments significantly reduced vs placebo in 139 people over 12 weeks.Benefit seen | Not reported Recorded unit: Not reported | Sample (as reported): 139 Follow-up: 12 weeks | Randomised trial · 2017 Study detailsImprovement of activity-related knee joint discomfort following supplementation of specific collagen peptides. Randomized Controlled Trial PMID 28177710 |
|---|